The CDC data shows the estimated biweekly prevalence of the most common SARS-CoV-2 lineages circulating in the U.S., based on more than 40,000 sequences collected through the agency’s national genomic surveillance since Dec 20.
For the weeks Jan. 3 to March 27, the CDC estimates these three variants each account for nearly 50 percent of all U.S. COVID-19 cases.
B.1.1.7 (first identified in U.K.): 44.1 percent
P.1 (first identified in Brazil): 1.4
B.1.351 (first identified in South Africa): 0.7
More articles on public health:
UK variant more transmissible, not deadlier, study finds
Hispanic Americans see highest COVID-19 hospitalization rates across US: 6 CDC findings
Unvaccinated teens, children driving COVID-19 surges
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
